Results 1 to 6 of 6
Page 1 of 1
TypeTitleAuthor(s)YearViews
miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma
Journal:
PLoS One
Publisher:
Public Library of Science. The Journal's web site is located at http://www.plosone.org/home.action
Liu, ML; Xu, Z; Shek, HP; Wong, KF; Lee, NPY; Poon, RTP; Chen, J; Luk, JMC201449
 
Oncofetal Molecules as Biomarkers and Drug Targets for Hepatic Cancer
Book:
New Advances on Disease Biomarkers and Molecular Targets in Biomedicine
Publisher:
Humana Press
Shek, HP; Lai, TCW; Fatima, S; Lee, NPY201335
 
Implications of the use of eukaryotic translation initiation factor 5A (eIF5A) for prognosis and treatment of hepatocellular carcinoma
Journal:
International Journal of Hepatology
Shek, HP; Fatima, S; Lee, NPY201272
 
Tumorigenic properties of serine peptidase inhibitor, Kazal type 1 (SPINK1) in hepatocellular carcinoma
Proceedings/Conference:
18th Hong Kong International Cancer Congress, HKICC 2011
Shek, HP; Lee, NPY201175
 
Targeting Serine Peptidase Inhibitor, Kazal Type 1 (SPINK1) as a Potential Treatment for Hepatocellular Carcinoma
Proceedings/Conference:
Annual Conference of the International Liver Cancer Association (ILCA)
Publisher:
The International Liver Cancer Association (ILCA).
Shek, HP; Luk, JMC; Lee, NPY2011114
 
The role of serine peptidase inhibitor, Kazal type I (SPINK1) in hepatocellular carcinoma (Poster Presentation)Shek, HP; Luk, JMC; Kwong, A; Lee, NPY2010102
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download